Ionis Pharmaceuticals, Inc. (IONS) vs Rhythm Pharmaceuticals, Inc. (RYTM)
Ionis Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Ionis Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. are of similar size ($7.4B and $6.8B). Rhythm Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 53.5% against −7.41%. Ionis Pharmaceuticals, Inc. has the higher net margin (−64.7% vs −87.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Ionis Pharmaceuticals, Inc. leads on 9 and Rhythm Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | IONS | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.17% | 89.00% | 65.16% |
| Operating margin | (68.00%) | (83.62%) | 0.00% |
| Net margin | (64.66%) | (87.62%) | 0.00% |
| Free cash flow margin | (64.93%) | (43.91%) | 0.00% |
| Return on equity | (105.50%) | (461.65%) | (57.72%) |
| Return on assets | (18.90%) | (51.91%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack